We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

50 hedge funds and large institutions have $38.9M invested in Kindred Biosciences, Inc. in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

11% more funds holding

Funds holding: 45 → 50 (+5)

38% less capital invested

Capital invested by funds: $62.9M → $38.9M (-$24M)

Holders
50
Holders Change
+5
Holders Change %
+11.11%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
22
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
+$6.78M
2
AI
Ariel Investments
Illinois
+$3.47M
3
Wells Fargo
Wells Fargo
California
+$694K
4
Renaissance Technologies
Renaissance Technologies
New York
+$678K
5
EC
EcoR1 Capital
California
+$507K

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$11.3M
2
SCM
Sarissa Capital Management
Connecticut
-$3.58M
3
CAM
Cormorant Asset Management
Massachusetts
-$1.71M
4
DM
Deerfield Management
New York
-$1.45M
5
RSCM
Rock Springs Capital Management
Maryland
-$1.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$85K -$6.34K -1,368 -5%
TRCT
27
Tower Research Capital (TRC)
New York
$83K +$99.4K +21,420 +704%
Morgan Stanley
28
Morgan Stanley
New York
$78K +$5.71K +1,232 +6%
BIT
29
BlackRock Institutional Trust
California
$76K +$104K +22,355 New
BA
30
BlackRock Advisors
Delaware
$67K +$4.84K +1,043 +6%
UBS Group
31
UBS Group
Switzerland
$66K +$21.5K +4,638 +32%
Deutsche Bank
32
Deutsche Bank
Germany
$62K +$64.3K +13,867 +299%
Northern Trust
33
Northern Trust
Illinois
$59K – – –
EAM
34
Evanson Asset Management
California
$56K – – –
BG
35
BlackRock Group
United Kingdom
$50K – – –
NFGCM
36
Norman Fields Gottscho Capital Management
New York
$47K -$13.2K -2,850 -17%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$38K +$4.17K +900 +9%
VKH
38
Virtu KCG Holdings
New York
$38K +$52.3K +11,278 New
CS
39
Credit Suisse
Switzerland
$37K +$50.2K +10,817 New
ARTA
40
A.R.T. Advisors
New York
$35K +$48.6K +10,474 New
NFA
41
Nationwide Fund Advisors
Ohio
$27K +$14.4K +3,100 +63%
Walleye Trading
42
Walleye Trading
New York
$26K +$28.3K +6,100 +381%
Acadian Asset Management
43
Acadian Asset Management
Massachusetts
$13K +$17.7K +3,812 New
CG
44
Cutler Group
California
$12K +$16.6K +3,570 New
BJ
45
BlackRock Japan
Japan
$10K +$13.8K +2,966 New
BIM
46
BlackRock Investment Management
Delaware
$8K – – –
MA
47
MUFG Americas
New York
$6K +$8.39K +1,810 New
Citigroup
48
Citigroup
New York
$2K +$2.05K +442 New
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$1K +$1.27K +274 +361%
Jennison Associates
50
Jennison Associates
New York
– -$11.3M -2,173,893 Closed
1
2
3

KIN Hedge Fund Activity: Q4 2015 in Review

50 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2015, worth a combined $38.9M — down 38% from $62.9M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new KIN positions and 10 closed out — a net gain of 5 holders — while 22 added to existing stakes and 3 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $6.78M. The largest seller was Jennison Associates, exiting entirely with an estimated $11.3M sold.

  • 50 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2015, up from 45 in Q3 2015.
  • Funds reported $38.9M of Kindred Biosciences, Inc. stock for Q4 2015, down 38% quarter-over-quarter.
  • 15 funds opened new Kindred Biosciences, Inc. positions in Q4 2015 and 10 closed out, a net change of +5 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q4 2015 was Park West Asset Management, an estimated $6.78M added.
  • The largest Kindred Biosciences, Inc. seller in Q4 2015 was Jennison Associates, an estimated $11.3M sold.

Based on aggregated 13F filings for Q4 2015.